Pay in 4 interest-free payments of $5.11 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Experimental research is an earlier stage
The GIP receptor-mediated effects on adipose tissue metabolism appear to target visceral fat preferentially, making tirzepatide particularly effective for this metabolically high-risk phenotype
Currently, three of the incretin-based products are FDA approved for weight loss Wegovy (semaglutide), Saxenda (liraglutide), and Zepbound (tirzepatide)
If you're stopping due to achieving goals, your provider can help establish realistic expectations and monitoring plans
.png)
US$ 23.39
US$ 25.09
US$ 28.27
US$ 29.50
US$ 25.23
US$ 23.13
US$ 20.01
US$ 29.50
